Clancy J Clark1, Nora F Fino, Norman Clark, Armando Rosales, Girsh Mishra, Rishi Pawa. 1. *Department of General Surgery, Division of Surgical Oncology †Division of Public Health Sciences ‡Department of Internal Medicine, Division of Gastroenterology, Wake Forest Baptist Health, Winston-Salem, NC §Department of Surgery, Cleveland Clinic of Florida, Weston, FL.
Abstract
GOALS: The aim of this study was to characterize current trends in the use of endoscopic retrograde cholangiopancreatography (ERCP) in the United States for patients hospitalized with chronic pancreatitis. BACKGROUND: Historically, ERCP was the primary tool for diagnostic and therapeutic management of chronic pancreatitis. With increased availability of magnetic resonance imaging and endoscopic ultrasound, indications for ERCP are being redefined. STUDY: We performed a retrospective cohort study using the Nationwide Inpatient Sample from 1998 to 2010. We identified patients with a primary discharge diagnosis of chronic pancreatitis who underwent ERCP. We excluded patients diagnosed with biliary, gallbladder, or pancreatic neoplasm and patients who underwent gallbladder or pancreatic operation during the same admission. We analyzed patient and hospital characteristics, length of stay, and in-hospital mortality, and adjusted for weighted sample schema. RESULTS: During the study period, 29,318 patients with chronic pancreatitis (mean age 52 y, 57.2% female) underwent ERCP during their hospitalization. The majority of patients were white (56.1%). The majority of procedures were performed at large (72.4%), urban (95.2%), and academic (69.0%) hospitals. Mean hospital charges were $32,929 (SE= $1605). Mean length of stay was 6 days (SE=0.3), with in-hospital mortality of 0.76%. Over the study period, the number of procedures has decreased significantly (P<0.001). CONCLUSIONS: In the United States, ERCP has been an important diagnostic and therapeutic tool for chronic pancreatitis. Over the last decade, ERCP has become an uncommon inpatient procedure for chronic pancreatitis.
GOALS: The aim of this study was to characterize current trends in the use of endoscopic retrograde cholangiopancreatography (ERCP) in the United States for patients hospitalized with chronic pancreatitis. BACKGROUND: Historically, ERCP was the primary tool for diagnostic and therapeutic management of chronic pancreatitis. With increased availability of magnetic resonance imaging and endoscopic ultrasound, indications for ERCP are being redefined. STUDY: We performed a retrospective cohort study using the Nationwide Inpatient Sample from 1998 to 2010. We identified patients with a primary discharge diagnosis of chronic pancreatitis who underwent ERCP. We excluded patients diagnosed with biliary, gallbladder, or pancreatic neoplasm and patients who underwent gallbladder or pancreatic operation during the same admission. We analyzed patient and hospital characteristics, length of stay, and in-hospital mortality, and adjusted for weighted sample schema. RESULTS: During the study period, 29,318 patients with chronic pancreatitis (mean age 52 y, 57.2% female) underwent ERCP during their hospitalization. The majority of patients were white (56.1%). The majority of procedures were performed at large (72.4%), urban (95.2%), and academic (69.0%) hospitals. Mean hospital charges were $32,929 (SE= $1605). Mean length of stay was 6 days (SE=0.3), with in-hospital mortality of 0.76%. Over the study period, the number of procedures has decreased significantly (P<0.001). CONCLUSIONS: In the United States, ERCP has been an important diagnostic and therapeutic tool for chronic pancreatitis. Over the last decade, ERCP has become an uncommon inpatient procedure for chronic pancreatitis.
Authors: Keith Bodger; Katherine Bowering; Sanchoy Sarkar; Elizabeth Thompson; Michael G Pearson Journal: Gastrointest Endosc Date: 2011-08-11 Impact factor: 9.427
Authors: Jan Grendar; Abdel A Shaheen; Robert P Myers; Robyn Parker; Charles M Vollmer; Chad G Ball; May Lynn Quan; Gilaad G Kaplan; Tariq Al-Manasra; Elijah Dixon Journal: Arch Surg Date: 2011-10-17
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Ann Intern Med Date: 2007-10-16 Impact factor: 25.391
Authors: Niels A van der Gaag; Thomas M van Gulik; Olivier R C Busch; Mirjam A Sprangers; Marco J Bruno; Chantal Zevenbergen; Dirk J Gouma; Marja A Boermeester Journal: Ann Surg Date: 2012-04 Impact factor: 12.969
Authors: Djuna L Cahen; Dirk J Gouma; Yung Nio; Erik A J Rauws; Marja A Boermeester; Olivier R Busch; Jaap Stoker; Johan S Laméris; Marcel G W Dijkgraaf; Kees Huibregtse; Marco J Bruno Journal: N Engl J Med Date: 2007-02-15 Impact factor: 91.245
Authors: P Katsinelos; J Kountouras; G Chatzimavroudis; C Zavos; S Terzoudis; I Pilpilidis; G Paroutoglou Journal: Endoscopy Date: 2010-11-24 Impact factor: 10.093
Authors: Suzanne M Jeurnink; Jan Werner Poley; Ewout W Steyerberg; Ernst J Kuipers; Peter D Siersema Journal: Gastrointest Endosc Date: 2008-03-04 Impact factor: 9.427